Literature DB >> 19383939

FSHD region gene 1 (FRG1) is crucial for angiogenesis linking FRG1 to facioscapulohumeral muscular dystrophy-associated vasculopathy.

Ryan D Wuebbles1, Meredith L Hanel, Peter L Jones.   

Abstract

The genetic lesion that is diagnostic for facioscapulohumeral muscular dystrophy (FSHD) results in an epigenetic misregulation of gene expression, which ultimately leads to the disease pathology. FRG1 (FSHD region gene 1) is a leading candidate for a gene whose misexpression might lead to FSHD. Because FSHD pathology is most prominent in the musculature, most research and therapy efforts focus on muscle cells. Previously, using Xenopus development as a model, we showed that altering frg1 expression levels systemically leads to aberrant muscle development, illustrating the potential for aberrant FRG1 levels to disrupt the musculature. However, 50-75% of FSHD patients also exhibit retinal vasculopathy and FSHD muscles have increased levels of vascular- and endothelial-related FRG1 transcripts, illustrating an underlying vascular component to the disease. To date, no FSHD candidate gene has been proposed to affect the vasculature. Here, we focus on a role for FRG1 expression in the vasculature. We found that endogenous frg1 is expressed in both the developing and adult vasculature in Xenopus. Furthermore, expression of FRG1 was found to be essential for the development of the vasculature, as a knockdown of FRG1 resulted in decreased angiogenesis and reduced expression of the angiogenic regulator DAB2. Conversely, tadpoles subjected to frg1 overexpression displayed the pro-angiogenic phenotypes of increased blood vessel branching and dilation of blood vessels, and developed edemas, suggesting that their circulation was disrupted. Thus, the systemic upregulation of the FRG1 protein shows the potential for acquiring a disrupted vascular phenotype, providing the first link between a FSHD candidate gene and the vascular component of FSHD pathology. Overall, in conjunction with our previous analysis, we show that FRG1 overexpression is capable of disrupting both the musculature and vasculature, recapitulating the two most prominent features of FSHD.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19383939      PMCID: PMC2675802          DOI: 10.1242/dmm.002261

Source DB:  PubMed          Journal:  Dis Model Mech        ISSN: 1754-8403            Impact factor:   5.758


  34 in total

1.  Expression profile of FSHD supports a link between retinal vasculopathy and muscular dystrophy.

Authors:  R J Osborne; S Welle; S L Venance; C A Thornton; R Tawil
Journal:  Neurology       Date:  2006-12-06       Impact factor: 9.910

2.  Xapelin and Xmsr are required for cardiovascular development in Xenopus laevis.

Authors:  Masafumi Inui; Akimasa Fukui; Yuzuru Ito; Makoto Asashima
Journal:  Dev Biol       Date:  2006-06-22       Impact factor: 3.582

3.  Expression of a new G protein-coupled receptor X-msr is associated with an endothelial lineage in Xenopus laevis.

Authors:  E Devic; L Paquereau; P Vernier; B Knibiehler; Y Audigier
Journal:  Mech Dev       Date:  1996-10       Impact factor: 1.882

4.  Isolation and characterization of mesoangioblasts from facioscapulohumeral muscular dystrophy muscle biopsies.

Authors:  Roberta Morosetti; Massimiliano Mirabella; Carla Gliubizzi; Aldobrando Broccolini; Cristina Sancricca; Mario Pescatori; Teresa Gidaro; Giorgio Tasca; Roberto Frusciante; Pietro Attilio Tonali; Giulio Cossu; Enzo Ricci
Journal:  Stem Cells       Date:  2007-08-30       Impact factor: 6.277

5.  Muscular dystrophy candidate gene FRG1 is critical for muscle development.

Authors:  Meredith L Hanel; Ryan D Wuebbles; Peter L Jones
Journal:  Dev Dyn       Date:  2009-06       Impact factor: 3.780

6.  The inhibitory effects of Disabled-2 (Dab2) on Wnt signaling are mediated through Axin.

Authors:  Y Jiang; C Prunier; P H Howe
Journal:  Oncogene       Date:  2007-10-08       Impact factor: 9.867

7.  A Myc-Slug (Snail2)/Twist regulatory circuit directs vascular development.

Authors:  Claudia O Rodrigues; Steve T Nerlick; Elsie L White; John L Cleveland; Mary Lou King
Journal:  Development       Date:  2008-06       Impact factor: 6.868

8.  Engineered telomeres in transgenic Xenopus laevis.

Authors:  Ryan Wuebbles; Peter L Jones
Journal:  Transgenic Res       Date:  2007-02-15       Impact factor: 2.788

Review 9.  Wnt/Frizzled signaling in angiogenesis.

Authors:  Marielba Zerlin; Martin A Julius; Jan Kitajewski
Journal:  Angiogenesis       Date:  2008-02-06       Impact factor: 9.596

10.  The receptor tyrosine kinase EphB4 and ephrin-B ligands restrict angiogenic growth of embryonic veins in Xenopus laevis.

Authors:  P M Helbling; D M Saulnier; A W Brändli
Journal:  Development       Date:  2000-01       Impact factor: 6.868

View more
  24 in total

1.  RNA interference improves myopathic phenotypes in mice over-expressing FSHD region gene 1 (FRG1).

Authors:  Lindsay M Wallace; Sara E Garwick-Coppens; Rossella Tupler; Scott Q Harper
Journal:  Mol Ther       Date:  2011-07-05       Impact factor: 11.454

Review 2.  Facioscapulohumeral muscular dystrophy (FSHD): an enigma unravelled?

Authors:  Mark Richards; Frédérique Coppée; Nick Thomas; Alexandra Belayew; Meena Upadhyaya
Journal:  Hum Genet       Date:  2011-10-09       Impact factor: 4.132

3.  Facioscapulohumeral muscular dystrophy region gene-1 (FRG-1) is an actin-bundling protein associated with muscle-attachment sites.

Authors:  Qian Liu; Takako Iida Jones; Vivian W Tang; William M Brieher; Peter L Jones
Journal:  J Cell Sci       Date:  2010-03-09       Impact factor: 5.285

4.  Facioscapulohumeral muscular dystrophy (FSHD) region gene 1 (FRG1) expression and possible function in mouse tooth germ development.

Authors:  Kana Hasegawa; Hiroko Wada; Kengo Nagata; Hiroaki Fujiwara; Naohisa Wada; Hirotaka Someya; Yurie Mikami; Hidetaka Sakai; Tamotsu Kiyoshima
Journal:  J Mol Histol       Date:  2016-05-27       Impact factor: 2.611

Review 5.  Deciphering transcription dysregulation in FSH muscular dystrophy.

Authors:  Melanie Ehrlich; Michelle Lacey
Journal:  J Hum Genet       Date:  2012-06-21       Impact factor: 3.172

6.  Facioscapulohumeral muscular dystrophy region gene 1 is a dynamic RNA-associated and actin-bundling protein.

Authors:  Chia-Yun Jessica Sun; Silvana van Koningsbruggen; Steven W Long; Kirsten Straasheijm; Rinse Klooster; Takako I Jones; Michel Bellini; Lyne Levesque; William M Brieher; Silvère M van der Maarel; Peter L Jones
Journal:  J Mol Biol       Date:  2011-06-15       Impact factor: 5.469

Review 7.  Current status and future prospect of FSHD region gene 1.

Authors:  Arman Kunwar Hansda; Ankit Tiwari; Manjusha Dixit
Journal:  J Biosci       Date:  2017-06       Impact factor: 1.826

8.  BAC TG-EMBED: one-step method for high-level, copy-number-dependent, position-independent transgene expression.

Authors:  Qian Bian; Andrew S Belmont
Journal:  Nucleic Acids Res       Date:  2010-04-12       Impact factor: 16.971

Review 9.  The cell biology of disease: FSHD: copy number variations on the theme of muscular dystrophy.

Authors:  Daphne Selvaggia Cabianca; Davide Gabellini
Journal:  J Cell Biol       Date:  2010-12-13       Impact factor: 10.539

10.  DUX4c is up-regulated in FSHD. It induces the MYF5 protein and human myoblast proliferation.

Authors:  Eugénie Ansseau; Dalila Laoudj-Chenivesse; Aline Marcowycz; Alexandra Tassin; Céline Vanderplanck; Sébastien Sauvage; Marietta Barro; Isabelle Mahieu; Axelle Leroy; India Leclercq; Véronique Mainfroid; Denise Figlewicz; Vincent Mouly; Gillian Butler-Browne; Alexandra Belayew; Frédérique Coppée
Journal:  PLoS One       Date:  2009-10-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.